Clinical Trials Sponsored by The Hindin Center
Total 6790 results
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate Cancer PatientsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematopoietic Stem Cell Transplantation | Graft-versus-host Disease
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic Adenocarcinoma | Advanced AdenocarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedADVANCED HEPATOCELLULAR CARCINOMA (HCC)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnRefractory Malignant AscitesUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedClinical Stage III Nodal or Intransit Disease or Resectable Stage IV MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myelogenous LeukemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPatients With Lung, Breast, Head and Neck, or Pelvic MalignanciesUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaTerminated
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPancreatic AdenocarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate AdenocarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedQuality of Life | Surgical Wound | Scar | Skin Cancer Face | Mohs Micrographic Surgery
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHistological or Cytological Diagnosis of Pancreatic CarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedA Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of PennsylvaniaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUnresectable Paraganglioma | Recurrent Pheochromocytoma | Advanced Metastatic Paraganglioma | Advanced Metastatic Pheochromocytoma | Recurrent Paraganglioma | Unresectable PheochromocytomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedSubjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the OropharynxUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPleural Malignant MesotheliomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHigh Risk MDS or AML PatientsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedQuality of Life | Surgical Wound | Skin Cancer Face | Peer MentorshipUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-Small Cell Lung Carcinoma (NSCLC)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBarrett's EsophagusUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnSevere or Mild Toxicity From Radiotherapy and/or ChemotherapyUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBRCA1/2 NegativeUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedLeukemia | AML | CML | Myeloid LeukemiasUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedRenal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdenocarcinoma | Rectal Cancer | Metastasis | Colon CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted